• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Spexis announces promising data with balixafortide with various therapies

    GLOBENEWSWIRE

    Spexis announces promising pre-clinical data with balixafortide in combination

    GLOBENEWSWIRE

    Spexis announces positive renal impairment trial results with balixafortide

    GLOBENEWSWIRE

    Polyphor provides update on the future of the FORTRESS study of balixafortide

    BLOOMBERG

    Polyphor Provides Update on the Phase III FORTRESS Study of Balixafortide

    GLOBENEWSWIRE

    Polyphor flops a phase 3, jeopardizing its future

    FIERCEBIOTECH

    Polyphor Announces Third Positive Data Safety Monitoring Board (DSMB)

    GLOBENEWSWIRE

    Polyphor completes recruitment in Phase III trial of balixafortide

    PHARMIWEB

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.